Ibio Inc
Change company Symbol lookup
Select an option...
IBIO Ibio Inc
JPS Nuveen Preferred & Income Securities Fund
EFSC Enterprise Financial Services Corp
CYPS Cyclo3pss Corp
CXW CoreCivic Inc
STM STMicroelectronics NV
NYT New York Times Co
SOS Sos Ltd
CLOV Clover Health Investments Corp

Health Care : Biotechnology | Small Cap Value
Company profile

iBio, Inc. is a developer of next-generation biopharmaceuticals using its proprietary artificial intelligence (AI)-Driven Discovery Platform and FastPharming Manufacturing System. The Company is focusing its technologies on the research and development of novel products at its Drug Discovery Center in California. The Company through its FastPharming Manufacturing System and GlycaneeringSM Technologies develop its portfolio of proprietary biologic drug candidates. The Company operates through two segments: Biopharmaceuticals, and Bioprocessing. Its Biopharmaceuticals segment is engaged in large molecule discovery, development, and licensing activities. Its Bioprocessing segment is engaged in contract development and manufacturing services for recombinant proteins. Its pipeline includes IBIO-100, IBIO-101, IBIO-202, and IBIO-400. Its subsidiary, iBio CDMO LLC, provides FastPharming Contract Development and Manufacturing Services along with GlycaneeringSM Development Services.

Closing Price
Day's Change
0.10 (6.25%)
B/A Size
Day's High
Day's Low
(Heavy Day)

10-day average volume:

BlackBerry Ltd. Stock Falls Friday, Underperforms Market

4:39 pm ET September 30, 2022 (MarketWatch)

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of BlackBerry Ltd. (BB.T) slipped 2.08% to $4.70 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 1.51% to 3,585.62 and Dow Jones Industrial Average falling 1.71% to 28,725.51. This was the stock's third consecutive day of losses. BlackBerry Ltd. closed $7.69 below its 52-week high ($12.39), which the company achieved on November 3rd.

The stock underperformed when compared to some of its competitors Friday, as CrowdStrike Holdings Inc. Cl A (CRWD) fell 0.54% to $164.81, VMware Inc. (VMW) fell 0.95% to $106.46, and Citrix Systems Inc. (CTXS) rose 0.04% to $103.90. Trading volume (4.9 M) remained 560,007 below its 50-day average volume of 5.5 M.

Data source: Dow Jones Market Data, FactSet. Data compiled September 30, 2022.


(END) Dow Jones Newswires

September 30, 2022 16:39 ET (20:39 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.